ARK
AAKG.DE
IE000O5M6XO1
ARK Genomic Revolution UCITS ETF
Loading chart...

About this ETF

The ETF invests in companies from around the world that are expected to derive revenue from technological innovations in the genomic healthcare sector. The stocks included are filtered according to ESG criteria (environmental, social and corporate governance).

TER
0.75%

Total Expense Ratio per year

Fund Size
€77.4M

Assets under management

Holdings
33

Underlying equities

Dividend Yield
-

Accumulating

Fundamentals & Estimates

Weighted valuation multiples and analyst forecasts

Valuation Multiples
Weighted P/E
37.81
Weighted Fwd P/E
-22.65
💰 Revenue Estimates
Current Year CY
+46.02% ⌀ 14 Analysts Coverage
Next Year NY
+53.55% ⌀ 14 Analysts Coverage
📈 EPS Estimates (Earnings Per Share)
Current Year CY
+5.77% ⌀ 10 Analysts Coverage
Next Year NY
+49.84% ⌀ 10 Analysts Coverage

Related ETFs

iShares
HEAL.L • iShares
iShares Healthcare Innovation UCITS ETF
10.71 USD
TER 0.4% 1Y +28.6%
ARK
ARXK.DE • ARK
ARK Innovation UCITS ETF
8.99 EUR
TER 0.75% 1Y +19.1%
L&G
DOCT.L • L&G
L&G Healthcare Technology & Innovation UCITS ETF
18.19 USD
TER 0.49% 1Y +41.7%
Xtrackers
GTIS.DE • Xtrackers
Xtrackers World Small Cap Green Tech Innovators UCITS ETF 1C
39.45 EUR
TER 0.45% 1Y +25.5%
L&G
BIOT.L • L&G
L&G Pharma Breakthrough UCITS ETF
14.3 USD
TER 0.49% 1Y +13.1%
Xtrackers
GTIL.DE • Xtrackers
Xtrackers World Green Tech Innovators UCITS ETF 1C
34.94 EUR
TER 0.35% 1Y +15.8%
VanEck
IE000B9PQW54.SG • VanEck
VanEck Genomics and Healthcare Innovators UCITS ETF
24.71 EUR
TER 0.35%
Xtrackers
XGEN.L • Xtrackers
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C
44.06 USD
TER 0.3% 1Y +71.1%
ETF Profile
Provider
ARK
ARK
Fund Type
ETF
Inception Date
04/12/2024 (2 yrs)
Region
World
Country
-
Strategy
-
Distribution Policy
Accumulating
Replication
Full replication
Sustainable
Yes

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
28/100 Low (Concentration Risk)
Diversification Score
28/100 Low (Concentration Risk)
3Y Volatility
46.0% p.a.
Max Drawdown (3Y)
-44.0%
Sharpe Ratio (3Y)
0.78
Notes & Warnings
Fund Volume (AUM) Solid fund volume
⚠️ Elevated valuation: Avg P/E of 37.8
🟡 Moderate analyst coverage (9.9 analysts)
⚠️ Elevated top 10 holdings concentration: 58% of fund in top 10 positions.
🔴 Severe sector concentration risk: 100% in "Healthcare".
⚠️ Industry concentration: 40% in "Biotechnology".
⚠️ Elevated Regulatory & Policy Risk: 100% in heavily regulated industries (defense, regulated utilities, healthcare policy).
ende